window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMOs & Manufacturing

  • Biologics & Biosimilars,CDMOs & Manufacturing,Chronic diseases,Drug Delivery & Formulation

    Nanexa extends feasibility agreement with major pharma company for long-acting formulation study

    The collaboration, Nanexa says, provides further proof that PharmaShell atomic [...]

    August 8, 2025
  • CDMOs & Manufacturing,Market Access & Commercialization,Partnerships & Funding,Research & Development

    Growing investor interest shifts toward mature UK life science companies amid regional funding imbalances

    New research from Pioneer Group, in collaboration with Beauhurst, reveals [...]

    August 7, 2025
  • CDMOs & Manufacturing,Regulatory Affairs,Supply Chain & Logistics,Uncategorised

    Cherwell to become AnalytiChem UK from September 2025

    Cleanroom microbiology solutions specialist Cherwell is set to be renamed [...]

    August 7, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Regulatory Affairs

    Citi Pharma joins forces with Chinese firm to boost antibiotic production in Pakistan

    Citi Pharma has partnered with Xin Weisheng to build an [...]

    August 7, 2025
  • CDMOs & Manufacturing,Movers & Shakers

    Aragen appoints Aniel Khubchandani to lead development and manufacturing solutions business

    Contract research, development and manufacturing organisation Aragen has appointed Aniel [...]

    August 7, 2025
  • CDMOs & Manufacturing,Movers & Shakers

    Christian Dowdeswell named managing director at Arcinova

    Arcinova, a UK-based Contract Research Development and Manufacturing Organisation (CRDMO) [...]

    August 6, 2025
  • CDMOs & Manufacturing,Clinical Trials,Data Management,Digital Health,Regulatory Affairs,Technology and platforms

    Advarra expands study collaboration with site-centered technology to improve startup process

    Advarra, known for regulatory reviews and clinical research technology, has [...]

    August 6, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Global health,Partnerships & Funding,Rare Diseases,Technology and platforms

    Sidra Medicine awarded $100K G-Rex grant for CAR-T manufacturing platform

    ScaleReady has awarded a $100,000 G-Rex grant to Sidra Medicine, [...]

    August 6, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Partnerships & Funding,Technology and platforms

    LNP pioneer Pieter Cullis joins Hongene’s scientific advisory board

    Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

    August 5, 2025
  • CDMOs & Manufacturing,Global health,Regulatory Affairs,Research & Development,Supply Chain & Logistics,Technology and platforms

    Axplora expands Vizag API capacity and confirms FDA inspection success at Indian sites

    Axplora has announced a €6.5 million investment at its Vizag [...]

    August 6, 2025
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • William Blair highlights Carterra as key player in AI-driven drug discovery shift
    Categories: Artificial Intelligence, Drug Development, Drug discovery, Research & Development, Technology and platforms
  • 23andMe study links genetics to GLP-1 weight loss outcomes and side effects
    Categories: Artificial Intelligence, Clinical Development, Genomics and sequencing, Obesity, Precision medicine, Technology and platforms
  • Life Biosciences raises $80M to advance gene therapy for optic neuropathies
    Categories: Clinical Trials, Funding, Opthalmology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top